232 related articles for article (PubMed ID: 33979618)
1. Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins.
Hiatt J; Cavero DA; McGregor MJ; Zheng W; Budzik JM; Roth TL; Haas KM; Wu D; Rathore U; Meyer-Franke A; Bouzidi MS; Shifrut E; Lee Y; Kumar VE; Dang EV; Gordon DE; Wojcechowskyj JA; Hultquist JF; Fontaine KA; Pillai SK; Cox JS; Ernst JD; Krogan NJ; Marson A
Cell Rep; 2021 May; 35(6):109105. PubMed ID: 33979618
[TBL] [Abstract][Full Text] [Related]
2. Efficient gene knockout in primary human and murine myeloid cells by non-viral delivery of CRISPR-Cas9.
Freund EC; Lock JY; Oh J; Maculins T; Delamarre L; Bohlen CJ; Haley B; Murthy A
J Exp Med; 2020 Jul; 217(7):. PubMed ID: 32357367
[TBL] [Abstract][Full Text] [Related]
3. A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells.
Hultquist JF; Schumann K; Woo JM; Manganaro L; McGregor MJ; Doudna J; Simon V; Krogan NJ; Marson A
Cell Rep; 2016 Oct; 17(5):1438-1452. PubMed ID: 27783955
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
Hildreth AD; Riggan L; O'Sullivan TE
STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
[TBL] [Abstract][Full Text] [Related]
5. Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins.
Naeimi Kararoudi M; Dolatshad H; Trikha P; Hussain SA; Elmas E; Foltz JA; Moseman JE; Thakkar A; Nakkula RJ; Lamb M; Chakravarti N; McLaughlin KJ; Lee DA
J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985369
[TBL] [Abstract][Full Text] [Related]
6. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.
Schumann K; Lin S; Boyer E; Simeonov DR; Subramaniam M; Gate RE; Haliburton GE; Ye CJ; Bluestone JA; Doudna JA; Marson A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10437-42. PubMed ID: 26216948
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
8. A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins.
Prior H; MacConnachie L; Martinez JL; Nicholl GCB; Beg AA
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29757293
[TBL] [Abstract][Full Text] [Related]
9. Ex Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer Cells.
Huang RS; Lai MC; Lin S
Curr Protoc; 2021 Sep; 1(9):e246. PubMed ID: 34529358
[TBL] [Abstract][Full Text] [Related]
10. Editing the immune system in vivo in mice using CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing of transplanted hematopoietic stem cells.
Wang R; Graham S; Gao L; Tam J; Levesque MC
Methods; 2021 Oct; 194():30-36. PubMed ID: 33422676
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Mature Primary Innate Immune Cells.
Riggan L; Hildreth AD; Rolot M; Wong YY; Satyadi W; Sun R; Huerta C; O'Sullivan TE
Cell Rep; 2020 May; 31(7):107651. PubMed ID: 32433960
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleoprotein Transfection for CRISPR/Cas9-Mediated Gene Knockout in Primary T Cells.
Oh SA; Seki A; Rutz S
Curr Protoc Immunol; 2019 Feb; 124(1):e69. PubMed ID: 30334617
[TBL] [Abstract][Full Text] [Related]
13. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
Kim H; Choi J; Won KH
BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
[TBL] [Abstract][Full Text] [Related]
14. Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins.
Wu CM; Roth TL; Baglaenko Y; Ferri DM; Brauer P; Zuniga-Pflucker JC; Rosbe KW; Wither JE; Marson A; Allen CDC
J Immunol Methods; 2018 Jun; 457():33-40. PubMed ID: 29614266
[TBL] [Abstract][Full Text] [Related]
15. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing.
Wei T; Cheng Q; Min YL; Olson EN; Siegwart DJ
Nat Commun; 2020 Jun; 11(1):3232. PubMed ID: 32591530
[TBL] [Abstract][Full Text] [Related]
16. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna.
Kumagai H; Nakanishi T; Matsuura T; Kato Y; Watanabe H
PLoS One; 2017; 12(10):e0186112. PubMed ID: 29045453
[TBL] [Abstract][Full Text] [Related]
18. Optimized Nonviral Gene Disruption in Primary Murine and Human Myeloid Cells.
Freund EC; Haag SM; Haley B; Murthy A
Methods Mol Biol; 2023; 2618():201-217. PubMed ID: 36905519
[TBL] [Abstract][Full Text] [Related]
19. Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes.
Liang Z; Chen K; Li T; Zhang Y; Wang Y; Zhao Q; Liu J; Zhang H; Liu C; Ran Y; Gao C
Nat Commun; 2017 Jan; 8():14261. PubMed ID: 28098143
[TBL] [Abstract][Full Text] [Related]
20. Electroporation and genetic supply of Cas9 increase the generation efficiency of CRISPR/Cas9 knock-in alleles in C57BL/6J mouse zygotes.
Alghadban S; Bouchareb A; Hinch R; Hernandez-Pliego P; Biggs D; Preece C; Davies B
Sci Rep; 2020 Oct; 10(1):17912. PubMed ID: 33087834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
